Skip to Search
Skip to Navigation
Skip to Main Content
Skip to Footer
About Us
Life Sciences Publications
Our Medicines
Topic Articles
Topic Discussions
Login
Google Translate
Select language
English
French
Spanish
Login
Username
*
Password
*
Staff Login
×
Google Translate
Select language
English
French
Spanish
Login
Menu
Site Search
Search Options
Resources
Everything
Advanced Search
Uptodate
All
Title Search
Author
Patients & Caregivers
Healthcare Providers
Researchers & Partners
Investors
menu
About Us
Life Sciences Publications
Our Medicines
Topic Articles
Topic Discussions
Google News
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Sage Therapeutics (NASDAQ:SAGE) Price Target Raised to $29.00 at JPMorgan Chase & Co. - MarketBeat
Demystifying Sage Therapeutics: Insights From 5 Analyst Reviews - Sage Therapeutics (NASDAQ:SAGE) - Benzinga
SAGE Therapeutics Board Member Announces Retirement - TipRanks.com - TipRanks
Teachers Retirement System of The State of Kentucky Reduces Stock Position in Sage Therapeutics, Inc. (NASDAQ ... - MarketBeat
SAGE THERAPEUTICS DL-0001 Trade Ideas — FWB:SG7 — TradingView - TradingView
Teachers Retirement System of The State of Kentucky Has $433000 Position in Sage Therapeutics, Inc. (NASDAQ:SAGE) - Defense World
Sage Therapeutics, Inc. (NASDAQ:SAGE) Shares Sold by Teachers Retirement System of The State of Kentucky - MarketBeat
Teachers Retirement System of The State of Kentucky Has $433,000 Position in Sage Therapeutics, Inc. (NASDAQ ... - MarketBeat
Relative Strength Alert For Sage Therapeutics - Nasdaq
Sage Therapeutics - Biogen Partnered Depression Drug Meets Main Goal In Late-stage Study - AOL
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »
×